List of Excipients in API pentoxifylline
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing pentoxifylline
Detailed excipient profiles for pentoxifylline
Excipient focus: CELLULOSE, MICROCRYSTALLINE
pentoxifylline drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | pentoxifylline | 0615-4523 |
| State of Florida DOH Central Pharmacy | pentoxifylline | 53808-0516 |
| State of Florida DOH Central Pharmacy | pentoxifylline | 53808-0758 |
| >Company | >Ingredient | >NDC |
pentoxifylline drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: D&C RED NO. 30
pentoxifylline drug variants containing D&C RED NO. 30
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | pentoxifylline | 0615-4523 |
| State of Florida DOH Central Pharmacy | pentoxifylline | 53808-0516 |
| State of Florida DOH Central Pharmacy | pentoxifylline | 53808-0758 |
| >Company | >Ingredient | >NDC |
pentoxifylline drug variants not containing D&C RED NO. 30
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
pentoxifylline drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | pentoxifylline | 70954-668 |
| >Company | >Ingredient | >NDC |
pentoxifylline drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
Excipient focus: FD&C BLUE NO. 2
pentoxifylline drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | pentoxifylline | 0615-4523 |
| State of Florida DOH Central Pharmacy | pentoxifylline | 53808-0516 |
| State of Florida DOH Central Pharmacy | pentoxifylline | 53808-0758 |
| >Company | >Ingredient | >NDC |
pentoxifylline drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C YELLOW NO. 6
pentoxifylline drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | pentoxifylline | 0615-4523 |
| State of Florida DOH Central Pharmacy | pentoxifylline | 53808-0516 |
| State of Florida DOH Central Pharmacy | pentoxifylline | 53808-0758 |
| ANI Pharmaceuticals Inc | pentoxifylline | 70954-668 |
| >Company | >Ingredient | >NDC |
pentoxifylline drug variants not containing FD&C YELLOW NO. 6
Excipient focus: HYDROXYETHYL CELLULOSE
pentoxifylline drug variants containing HYDROXYETHYL CELLULOSE
pentoxifylline drug variants not containing HYDROXYETHYL CELLULOSE
Excipient focus: HYDROXYPROPYL CELLULOSE
pentoxifylline drug variants containing HYDROXYPROPYL CELLULOSE
pentoxifylline drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
pentoxifylline drug variants containing HYPROMELLOSE
pentoxifylline drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
pentoxifylline drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | pentoxifylline | 70954-668 |
| >Company | >Ingredient | >NDC |
pentoxifylline drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
pentoxifylline drug variants containing HYPROMELLOSES
pentoxifylline drug variants not containing HYPROMELLOSES
Excipient focus: ISOPROPYL ALCOHOL
pentoxifylline drug variants containing ISOPROPYL ALCOHOL
pentoxifylline drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: MAGNESIUM STEARATE
pentoxifylline drug variants containing MAGNESIUM STEARATE
pentoxifylline drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MALTODEXTRIN
pentoxifylline drug variants containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | pentoxifylline | 70954-668 |
| >Company | >Ingredient | >NDC |
pentoxifylline drug variants not containing MALTODEXTRIN
Excipient focus: POLYDEXTROSE
pentoxifylline drug variants containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | pentoxifylline | 0615-4523 |
| State of Florida DOH Central Pharmacy | pentoxifylline | 53808-0516 |
| State of Florida DOH Central Pharmacy | pentoxifylline | 53808-0758 |
| >Company | >Ingredient | >NDC |
pentoxifylline drug variants not containing POLYDEXTROSE
Excipient focus: POLYETHYLENE GLYCOL
pentoxifylline drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | pentoxifylline | 53808-0516 |
| State of Florida DOH Central Pharmacy | pentoxifylline | 53808-0758 |
| ANI Pharmaceuticals Inc | pentoxifylline | 70954-668 |
| >Company | >Ingredient | >NDC |
pentoxifylline drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 8000
pentoxifylline drug variants containing POLYETHYLENE GLYCOL 8000
pentoxifylline drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYETHYLENE GLYCOLS
pentoxifylline drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | pentoxifylline | 0615-4523 |
| >Company | >Ingredient | >NDC |
pentoxifylline drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POVIDONE
pentoxifylline drug variants containing POVIDONE
pentoxifylline drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
pentoxifylline drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | pentoxifylline | 70954-668 |
| >Company | >Ingredient | >NDC |
pentoxifylline drug variants not containing POVIDONE K30
Excipient focus: POVIDONES
pentoxifylline drug variants containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | pentoxifylline | 0615-4523 |
| >Company | >Ingredient | >NDC |
pentoxifylline drug variants not containing POVIDONES
Excipient focus: SILICON DIOXIDE
pentoxifylline drug variants containing SILICON DIOXIDE
pentoxifylline drug variants not containing SILICON DIOXIDE
Excipient focus: TALC
pentoxifylline drug variants containing TALC
pentoxifylline drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
pentoxifylline drug variants containing TITANIUM DIOXIDE
pentoxifylline drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRIACETIN
pentoxifylline drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | pentoxifylline | 0615-4523 |
| State of Florida DOH Central Pharmacy | pentoxifylline | 53808-0516 |
| State of Florida DOH Central Pharmacy | pentoxifylline | 53808-0758 |
| >Company | >Ingredient | >NDC |
pentoxifylline drug variants not containing TRIACETIN
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
